These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17485742)

  • 1. Drug safety proposals and the intrusion of federal regulation into patient freedom and medical practice.
    Gottlieb S
    Health Aff (Millwood); 2007; 26(3):664-77. PubMed ID: 17485742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risks and benefits of risk-management plans.
    Meltzer D
    Health Aff (Millwood); 2007; 26(3):681-3. PubMed ID: 17485744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk management and intrusions on medical practice: striking a balance.
    Enzi MB; Kennedy EM
    Health Aff (Millwood); 2007; 26(3):678-80. PubMed ID: 17485743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The FDA and the IOM report.
    Galson SK
    N Engl J Med; 2007 Dec; 357(24):2520-1; author reply 2521-2. PubMed ID: 18077820
    [No Abstract]   [Full Text] [Related]  

  • 5. The pharmaceutical industry: friend or foe?
    Niebyl JR
    Am J Obstet Gynecol; 2008 Apr; 198(4):435-9. PubMed ID: 18395035
    [No Abstract]   [Full Text] [Related]  

  • 6. Sidelining safety--the FDA's inadequate response to the IOM.
    Smith SW
    N Engl J Med; 2007 Sep; 357(10):960-3. PubMed ID: 17804840
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk evaluation and mitigation strategies for drugs with abuse liability: public interest, special interest, conflicts of interest, and the industry perspective.
    Wright C; Schnoll S; Bernstein D
    Ann N Y Acad Sci; 2008 Oct; 1141():284-303. PubMed ID: 18991964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Institute of Medicine report on the FDA: where is the science?
    Philipson T; Jena AB; Sun E
    Health Econ; 2007 Mar; 16(3):219-21. PubMed ID: 17315264
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of academia and the research community in assisting the Food and Drug Administration to ensure U.S. drug safety.
    Lo Re V; Strom BL
    Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):818-25. PubMed ID: 17436357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A precarious balancing act--the role of the FDA as protector of public health and industry wealth.
    McCabe AR
    Suffolk Univ Law Rev; 2003; 36(3):787-819. PubMed ID: 16493844
    [No Abstract]   [Full Text] [Related]  

  • 11. Institute of Medicine, Congress seek solutions to FDA's safety woes through reform, funding.
    Finkelstein JB
    J Natl Cancer Inst; 2007 Jan; 99(2):104-7. PubMed ID: 17227990
    [No Abstract]   [Full Text] [Related]  

  • 12. The origins of American health libertarianism.
    Grossman LA
    Yale J Health Policy Law Ethics; 2013; 13(1):76-134. PubMed ID: 23815041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assuring the benefits of modern medicine for all Americans.
    Woodcock J
    Healthplan; 2003; 44(5):23-6. PubMed ID: 14556608
    [No Abstract]   [Full Text] [Related]  

  • 14. The federal preemption debate in pharmaceutical labeling product liability actions.
    Gross JM; Curry JA
    Tort Trial Insur Pract Law J; 2007; 43(1):35-70. PubMed ID: 18354866
    [No Abstract]   [Full Text] [Related]  

  • 15. Bush tails follow-ons.
    Fox J
    Nat Biotechnol; 2008 Apr; 26(4):366. PubMed ID: 18392007
    [No Abstract]   [Full Text] [Related]  

  • 16. Congress responds to the IOM drug safety report--in full.
    Psaty BM; Korn D
    JAMA; 2007 Nov; 298(18):2185-7. PubMed ID: 18000202
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of the pharmaceutical industry in disseminating pharmacovigilance practice in developing countries.
    Shani S; Yahalom Z
    Food Drug Law J; 2008; 63(3):701-11. PubMed ID: 19031669
    [No Abstract]   [Full Text] [Related]  

  • 18. The unfinished business of U.S. drug safety regulation.
    Evans BJ; Flockhart DA
    Food Drug Law J; 2006; 61(1):45-63. PubMed ID: 16838457
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmaceuticals and medical devices: FDA oversight. Issue brief.
    Berry MD
    Issue Brief Health Policy Track Serv; 2012 Dec; ():1-79. PubMed ID: 23297449
    [No Abstract]   [Full Text] [Related]  

  • 20. Access before approval--a right to take experimental drugs?
    Okie S
    N Engl J Med; 2006 Aug; 355(5):437-40. PubMed ID: 16885545
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.